Korro Bio, Inc.
KRRO
$20.15
$0.0750.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -42.75% | 12.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -42.75% | 12.29% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -42.75% | 12.29% | |||
| SG&A Expenses | -3.32% | -4.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.96% | 8.92% | |||
| Operating Income | -8.72% | -8.59% | |||
| Income Before Tax | -10.19% | -10.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.19% | -10.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.19% | -10.32% | |||
| EBIT | -8.72% | -8.59% | |||
| EBITDA | -9.16% | -9.22% | |||
| EPS Basic | -10.12% | -10.12% | |||
| Normalized Basic EPS | -10.11% | -10.66% | |||
| EPS Diluted | -10.12% | -10.12% | |||
| Normalized Diluted EPS | -10.11% | -10.66% | |||
| Average Basic Shares Outstanding | 0.07% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.07% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||